Rasna TherapeuticsRASP 
$0.000.00%24h
0.00%24h
Global rank35395
Market cap$3.09M
Change 7d0.00%
YTD Performance-48.05%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings-$4.44M
Dividend yield-
Main Sector
Healthcare
Category
Rasna Therapeutics (RASP) Total Liabilities
RASP Total Liabilities in 2022: $2.05M
According to Rasna Therapeutics latest financial reports the total liabilities of RASP is $2.05M, an increase of 15.65% to 2022. At the end of 2022 company had $1.77M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Rasna Therapeutics is responsible for during its operational activities.
Rasna Therapeutics (RASP) Total Liabilities History from 2023 to 2022
-
Value:-
RASP Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $2.05M | 15.65% |
| 2022 | $1.77M | -36.61% |
| 2021 | $2.80M | 3.35% |
| 2020 | $2.71M | 12.42% |
| 2019 | $2.41M | 180.99% |
| 2018 | $857.17K | - |
View the Top Total Liabilies Stocks
